{
    "nct_id": "NCT06668922",
    "official_title": "Fecal Bile Acids, Fecal Short Chain Fatty Acids and the Intestinal Microbiota in Patients with Irritable Bowel Syndrome (IBS) and Control Volunteers: Diet Challenge",
    "inclusion_criteria": "* Age 18-75\n* Individuals with irritable bowel syndrome (IBS)\n* Healthy volunteers (healthy controls) with no prior history of gastrointestinal (GI) disease or symptoms\n* No dietary restrictions other than vegetarian\nHealthy volunteers allowed\nMust have minimum age of 17 Years\nMust have maximum age of 65 Years",
    "exclusion_criteria": "* Inflammatory bowel disease, celiac disease, or certain types of abdominal cancer, as well as those with thyroid or liver issues\n* Abdominal surgery or abdominal radiation within 6 months of study participation, with an exception for C-section or gallbladder removal\n* Use of any prescription, over the counter, or herbal medications known to affect gastrointestinal function or study interpretation, such as opioids, inflammatory drugs or certain antidepressants, within 6 months prior to study participation for healthy volunteers, or within 2 days of study participation for participants with IBS.\n* An exception will be permitted for limited use of stable low doses of antidepressants for individuals who have been taking them for a period greater than one month.\n* Rescue medication such as Bisacodyl (dulcolax) to relieve severe constipation and allow for stool collection will be permitted when needed.\n* Use of Ozempic and Ozempic-type medications\n* Pregnant or breastfeeding women\n* Antibiotic use within 3 months of study participation\n* Use of prebiotics or probiotics within the 2 weeks before the study initiation\n* Regular tobacco use within the past 6 months",
    "miscellaneous_criteria": ""
}